Procalcitonin as a Prognostic Factor in Acute Cholangitis

Procalcitonin use in Acute Cholangitis


  • Bayram Yeşil Kırıkkale Üniversitesi Tıp Fakültesi, Gastroenetroloji Bilim Dalı
  • Bülent Ödemiş Ankara Şehir Hastanesi, Gastroenteroloji Kliniği
  • Mahmut Yüksel Ankara Şehir Hastanesi, Gastroenteroloji Kliniği
  • Zeki Mesut Yalın Kılıç Ankara Şehir Hastanesi, Gastroenteroloji Kliniği
  • Ertuğrul Kayaçetin Ankara Şehir Hastanesi, Gastroenteroloji Kliniği



Akut kolanjit, prokalsitonin, hastalık şiddeti, prognoz


Aim: In this study, we evaluated the efficacy of procalcitonin levels at admission in predicting disease severity and early biliary drainage in patients admitted to our hospital with a diagnosis of acute cholangitis.

Material and Method: The data of the patients who were treated in our clinic and whose procalcitonin level was studied within the first 24 hours were analyzed retrospectively. Tokyo criteria were used to evaluate the diagnosis of cholangitis. Within the scope of the study, 384 patients were evaluated.

Results: The median age of the patients was 69, and 215 (56%) of them were men. Biliary calculi were the most common predisposing factor. Of these, 170 (44.3%) were grade 1, 102 (26.5%) were grade 2 and 112 (29.2%) were grade 3. The median drainage time was 48 hours. At least one comorbidity was seen in 81.3% (312 patients).    Procalcitonin, white blood cell and C-reactive protein median values were 2.3 ng/ml (0.01-301.9), 11.6x10⁹/L (2410-55790) and 87.6 mg/L (3.4-413.2), respectively. It was determined that there was a statistically significant difference between the groups in terms of procalcitonin levels.

Conclusions: As a result of the analysis performed in our study, a strong correlation was found between procalcitonin level and disease severity and it was shown that serum procalcitonin level increased as the disease became more severe.


Download data is not yet available.


Afdhal, N., & Calderwood, S. B. (2022). Acute cholangitis: Clinical manifestations, diagnosis, and management.

Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.

Silangcruz K, Nishimura Y, Czech T, Kimura N, Yess J. Procalcitonin to Predict Severity of Acute Cholangitis and Need for Urgent Biliary Decompression: Systematic Scoping Review. J Clin Med. 2022;11(5):1155. Published 2022 Feb 22.

Joyce CD, Fiscus RR, Wang X, Dries DJ, Morris RC, Prinz RA. Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery. 1990;108(6):1097-1101.

Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515-518.

Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin as a useful biomarker for determining the need to perform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci. 2014;21(10):777-785.

Hamano K, Noguchi O, Matsumoto Y, et al. Usefulness of procalcitonin for severity assessment in patients with acute cholangitis. Clin Lab. 2013;59(1-2):177-183.

Umefune G, Kogure H, Hamada T, et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis: a single-center prospective study. J Gastroenterol. 2017;52(6):734-745.

Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998;26(6):1001-1006.

Schuetz P, Birkhahn R, Sherwin R, et al. Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study. Crit Care Med. 2017;45(5):781-789.

Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem. 2009;42(10-11):1025-1031.




How to Cite

Yeşil, B., Ödemiş, B., Yüksel, M., Kılıç, Z. M. Y., & Kayaçetin, E. (2023). Procalcitonin as a Prognostic Factor in Acute Cholangitis: Procalcitonin use in Acute Cholangitis. Chronicles of Precision Medical Researchers, 4(3), 285–289.